(MDRX) are worth at $12.36. (NASDAQ:MDRX) was trading at volume less than average, prior 52-week high was $13.83 and plunged -9.52% over the same period, trading at a volume of 2.71 million. Allscripts' continued reliance on mergers and acquisition activities presents a substantial integration risk for the company. The company achieved year to date performance of 21.06% and disseminated yield of 5.64% for the past six months.
MDRX has been the subject of several recent research reports. Oxford Asset Mngmt holds 0.53% in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) or 1.04 million shares. Bank of America Corporation began coverage on shares of Allscripts Healthcare Solutions in a research report on Monday, May 15th. The brokerage now has a $14.00 price objective on the software maker's stock. Finally, Bank of Montreal Can boosted its stake in Allscripts Healthcare Solutions by 60.2% in the first quarter.
Insider Trades for Allscripts Healthcare Solutions, Inc. show that the latest trade was made on 27 May 2017 where Farley (Brian P), the General Counsel completed a transaction type "Sell" in which 2106 shares were traded at a price of $11.38. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and nine have assigned a buy rating to the stock. The stock presently has a consensus rating of "Hold" and a consensus target price of $14.66. Last session Allscripts Healthcare Solutions, Inc. The company has a 50-day moving average price of $12.44 and a 200 day moving average price of $12.12.
Southwest Airlines Co. (NYSE:LUV) has a market cap of $33.03 billion and over the last 12 months, LUV has risen by 46%. Allscripts Healthcare Solutions has a 12-month low of $9.80 and a 12-month high of $14.30. (NASDAQ:MDRX) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.
NantHealth ( NH ) fell 17% to a two-month low after its Q2 adjusted loss widened to $0.18 per share from $0.15 loss per share a year earlier, missing Capital IQ's poll estimate of $0.15 loss per share. Return on Equity (ROE) stands at -15.8% and Return on Investment (ROI) of 3 percent. The firm had revenue of $426.10 million during the quarter, compared to analyst estimates of $424.94 million. The business's quarterly revenue was up 10.2% on a year-over-year basis.
In the latest earnings report the EPS was $-0.26 and is estimated to be $0.62 for the current year with 181,464,000 shares now outstanding. Blackrock invested 0% of its portfolio in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX). If you are viewing this story on another site, it was illegally stolen and reposted in violation of global copyright and trademark legislation. The legal version of this article can be read at https://sportsperspectives.com/2017/08/09/allscripts-healthcare-solutions-inc-nasdaqmdrx-stake-reduced-by-public-employees-retirement-system-of-ohio-updated.html.
25,000 shares valued at $301,383 were sold by Poulton Richard J. on Tuesday, May 16. The average 1-year price target for (LUV) reveals an average price target of $66.75 per share. The number of shares now owned by investors are 5.85 bln. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. (MDRX) holds floating shares of 179.64 million and 181.20 million outstanding shares. Dimensional Fund Advisors LP raised its stake in Allscripts Healthcare Solutions by 9.4% in the first quarter. Fiduciary Management Inc. WI now owns 6,045,110 shares of the software maker's stock worth $76,652,000 after buying an additional 1,341,870 shares in the last quarter. ING Groep NV bought a new stake in shares of Allscripts Healthcare Solutions during the second quarter valued at about $282,000. Thrivent Financial For Lutherans now owns 36,270 shares worth $463,000. Allscripts Healthcare Solutions's revenue for the quarter was up 10.2% compared to the same quarter previous year. RSI measures the speed and change of a stock price to warn investors when a stock's momentum has carried it too far. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Allscripts Healthcare Solutions by 9.5% in the first quarter. Following the sale, the president now directly owns 412,488 shares of the company's stock, valued at $4,974,605.28.
In the past 5 years, the stock showed growth of 3.69% per annum. Cipher Capital Lp owns 109,792 shares worth $1,401,000.
COPYRIGHT VIOLATION WARNING: "Allscripts Healthcare Solutions, Inc". The Firm operates through three divisions: Clinical and Financial Solutions, Population Health, and Netsmart.